Legere Pharmaceuticals Scottsdale Arizona

Niiki pharma devoile les resultats provisoires positifs des essais cliniques ...

The Phase I study conducted on patients with IS metastatic solid tumors resistant to conventional therapies. Prior to enrollment in clinical trials, patients All Ontario Monitoring Illicit Drugs Therapeutic Treatments classic and Ontario experienced disease progression of LOR LAST Their Treatment. Of the 24 patients enrolled, six (25%) had anti-tumor activity, manifesting itself by the stability of the disease and / ou tumor regression during a period of 12 weeks Less AU.

Among the six patients spond positively traitement AU, UN and patients with carcinoid tumor, the UN type non-pancreatic neuroendocrine tumor (not TNEP) reported a regression of his tumor and sub-NKP Treatment EST 1339, over 70 Weeks SINCE. In the five patients on the other observed a stabilization of disease for up to 24 Weeks Treatment with the NKP-1339. They suffer from tumors following non TNEP gastrinoma UN, UN colorectal cancer, lung cancer cells and two small non-UN the primary cancer of the unknown.

So far the treatment an NKP-1339 was well tolerated, side effects With moderate controllable. The most common side effects are attributable to the drug even a mild fever and flu-like mild symptoms 1-2, preventable medication WITH A classic. The maximum tolerated dose has not yet been reached, and increasing doses of NKP-1339 continues itself.

"We need new treatments to patients with cancer not TNEP. Antitumor activity of NKP-1339 in patients not these Two Important TNEP EST.Associated with the UN profile characterized by Side Effects Light, fel It's NKP-1339 UN New Treatment Very promising potentially make this disease, "said Dr. Daniel Von Hoff one.

"The preliminary results of this ongoing clinical trial demonstrate the antitumor activity and safety profile of the NKP-1339, and are confirming our preclinical Salary: According to which the drug target tumors and Active EST against various kinds of tumors.We are delighted to see years of research in collaboration with Team Niiki Pharma Chaleurs bear fruit, "says Keppler a Professor at the University of Vienna, the inventor of the NKP-1339.

Medical Concepts LLC – Helping Physicians To Build Their Practices ...

Medical Concepts LLC (MCL) was opened in December 2010 by Janice Wight and Sunny Willmington. Veterans of Pharmaceutical marketing, Janice and Sunny have worked together periodically for over over 13 years. Together they have re-organized marketing departments for 2 mid-sized natural pharmaceutical companies, and have collaborated on innumerable PR campaigns in both the healthcare and business sectors.

Combining their experience and talents, Janice and Sunny have opened Medical Concepts to focus on the most enjoyable and succesful aspect of their work – helping Physicians to build their practices. Partnering with Legere Pharmaceuticals of Scottsdale, AZ, they offer Physicians the ability to create new private labeled product lines with either their own formulas or existing Legere formulas.

For almost 40 years, Legere Pharmaceuticals have been a reputable full-line pharmaceutical company providing natural and alternative medicines to Physicians only, with a particular focus on obesity treatment. With a compounding pharmacy on-hand for private formulations, this company has worked with leading Integrative Physicians to create many trademarked, patented and unique medicines. Janice has worked with Legere since the early 80′s and when it came to selecting a pharmaceutical partner, they were the obvious choice. Always conservative and compliant with the FDA, Legere have a long-standing reputation for conducting ethical business, with safe, correctly and therapeutically dosed products. The opening of MCL marks the first and only time that Legere Pharmaceuticals have partnered with outside representatives for their product sales. This is testimony to the trusted, established relationship between the ownership at Legere and Medical Concepts. 

In 2010, Sunny opened Beautiful Words PR and Writing Services, which has since become a subsidiary of Medical Concepts LLC. Hand-in-hand with Physicians, Janice and Sunny use their knowledge to create lines of product to help enhance patient services, while boosting practice revenues. It makes good business sense to aid their Physicians with the PR and marketing of their new product lines – MCL offer PR guidance and strategies at no charge to their product clients, with heavy discounts on more in-depth services.

In our next blog post we will discuss what differentiates our product lines from others. Please feel free to sign up for our newsletter , a new resource for Physicians to garner practice building advice and ideas, alongside educational articles about the science behind our products. Please feel free to contact us  with any questions.

Companies and Their Brands: L-Z

AT & T toll-free national business buyer's guide

Trade names dictionary, Company index

Pharmaceutical manufacturers of the United States

Drug topics red book